Smart pills include smart ingestible pill-size devices and technologies (e.g., capsule endoscopy, pill-size drug/device combination-based ingestible electronic tablets, microsize capsules for patient monitoring, etc.), which are relatively new and more advanced and give better outcomes in the diagnosis, drug delivery, treatment adherence, health monitoring, and management associated with various diseases. This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for smart pills.
The format of the study is organized around the following:
- Detailed description of smart pills and technologies.
- Demographics and cost burden of targeted diseases.
- Regulatory structure.
- Market characterization, unmet need, market size, and segmentation.
- Market drivers and restraints.
- Detailed market projections through 2021.
- Competition and market shares.
- Pricing and reimbursement.
- Description of marketed and pipeline (R&D) products along with information about their regulatory status and clinical trials.
- Observations and conclusions regarding the future of ingestible smart pills.
- Profiles of market participants and associations.
- An overview of global market for smart pills and technologies.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Assessment of smart pills systems and technology markets, including market growth drivers, restraints and shares.
- Information on the regulatory structure, major developments influencing the market and the long-term outlook.
- Analyses of segments within the overall market including capsule endoscopy systems, gastrointestinal monitoring system, diagnosis and monitoring.
- Evaluation of industry activity, including licensing agreements, partnerships, and merger and acquisitions.
- Profiles of major players in the industry.
Study Goals and Objectives
Reasons For Doing This Study
Scope of Report
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
Epidemiology and Economic Burden
Common Gastrointestinal Diseases and Disorders
Inflammatory Bowel Disease (Ibd)
Gastroesophageal Reflux Disease (Gerd)
Obscure Gastrointestinal Bleeding
Digestive System Cancer
Small-Bowel Tumors/Small-Bowel Diseases
Other Chronic Disorders
Chapter 4 Gastrointestinal Capsule Endoscopy
Capsule Endoscope Components
Limitations and Risks
Types of Capsule Endoscopy
Small-Bowel Video Capsule Endoscopy
Esophageal Video Capsule Endoscopy
Colon Capsule Endoscopy
Key Marketed and Pipeline Products
R&D Pipeline Products
Chapter 5 Smart Pills For Patient Monitoring
Other Gastrointestinal Motility Disorders
Types and Applications of Smart Pills For Patient Monitoring
Monitoring Smart Pills (Ph, Temperature, Pressure)
Drug-Adherence Smart Pills
Key Marketed and Pipeline Products
Smartpill Motility Testing System (Medtronic)
Proteus Patch Including Ingestible Sensor (Proteus Digital Health)
Omom Ph Capsule Monitoring System (Chongqing Jinshan Science & Technology)
Abilify Smart Pill (Abilify Pill + Proteus Ingestible Sensor) (Proteus Digital Health and Otsuka Pharmaceuticals)
Smart Pill (Novartis Drugs + Proteus Ingestible Sensor) (Proteus Digital Health and Novartis)
Chapter 6 Smart Pills For Drug Delivery
Smart Pills For Oral Drug Delivery
Market Need For Drug-Delivery Smart Pills
Target Gastrointestinal Diseases and Indications
Inflammatory Bowel Syndrome Or Crohn’S Disease
Gastroesophageal Reflux Disease
Chronic Gastrointestinal Disorders
Characteristics of Drug-Delivery Smart Pills
Types of Drug-Release Mechanisms
Passive Release Mechanisms
Active Release Mechanisms
Marketed and R&D Pipeline Products
Intellicap (Medimetrics, Supported by Philips Research)
Novartis Robotic Pill (Novartis and Rani Therapeutics)
Novartis Smart Pill (Novartis and Proteus Digital)
Hydrophilic Sandwich (Hs) (Bio-Images Research)
Chapter 7 Market Size and Growth Analysis
Market Size and Growth Analysis by Region
Market Size and Growth Analysis by Application
Market Growth Drivers and Restraints
Gastrointestinal Capsule Endoscopy
Smart Pills For Patient Monitoring
Smart Pills For Drug Delivery
Chapter 8 Competitive Landscape In Smart Pills Market
Chapter 9 Market Strategy
Mergers and Acquisitions In Smart Pills Market
Recent Mergers and Acquisitions
Medtronic Acquired Covidien
Covidien Acquired Given Imaging
Given Imaging Acquired Smartpill's Smartpill Gi Monitoring System
Given Imaging Acquired Sierra Scientific
Given Imaging Acquired Medtronic's Bravo Ph Monitoring System
Future Strategic Landscape
Chapter 10 Regulatory Structure
Regulatory Systems For Drug/Device Combination Products
Regulatory Systems For Medical Devices and Drugs
Regulatory Systems For Medical Devices by Region
U.S. Fda Technical Considerations
Fda Policy For Low-Risk and General Wellness Devices
Fda Recalls and Safety Alerts
Regulatory Systems For Drugs by Region
Regulatory Systems For Smart Pills
Old Drug, New Medical Device
Old Drug, Old Medical Device
New Drug, Old Medical Device
New Drug, New Medical Device
Chapter 11 Pricing and Reimbursement
Other Asia Countries
Chapter 12 Outlook For Smart Pills and Technologies
Major Developments To Influence the Market
Technological Developments: Smart Ingestible Pill-Size Medical Sensors and Software Applications
Social Developments: Social Media and Rise of Smartphone Use
Demographic and Economic Trends: Income Growth In Developing Markets
Long-Term Outlook For Smart Pills
Chapter 13 Company Profiles
Bio-Images Research Ltd.
Chongqing Jinshan Science & Technology (Group) Co. Ltd.
Fujifilm Holdings Corp.
Given Imaging Inc. (Subsidiary of Medtronic)
Intromedic Co. Ltd.
Karl Storz Gmbh & Co. Kg
Medimetrics Personalized Drug Delivery Bv
Medivators Inc. (Subsidiary of Cantel Medical)
Pentax Medical Co.
Proteus Digital Health
Smartpill Corp. (Subsidiary of Medtronic)
Synectics Medical Ltd. (Trading As Synmed)
Chapter 14 Appendix a Acronyms
Chapter 15 Appendix B Professional Organizations
American Association For Cancer Research (Aacr)
American Gastroenterological Association (Aga)
American Society For Gastrointestinal Endoscopy (Asge)
Center For Drug Evaluation and Research (Cder)
Center For Devices and Radiological Health (Cdrh)
Center For Medicare and Medicaid Services (Cms)
European Databank For Medical Devices (Eudamed)
Food and Drug Administration (Fda Or Usfda)
Global Cancer Foundation
International Diabetes Federation (Idf)
International Federation of Pharmaceutical Manufacturers & Associations (Ifpma)
National Center For Biotechnology Information (Ncbi)
National Institute of Aging (Nia)
Pharmaceuticals and Medical Devices Agency (Pmda)
World Cancer Research Fund International
World Gastroenterology Organisation (Wgo)
World Health Organization (Who)
List of Tables
Table 1: Summary Table: Global Market For Smart Pills, by Region, Through 2021
Table 2: Mortality From Digestive Diseases, by Region, Through 2021
Table 3: Epidemiology of Colon Cancer, by Region, Through 2030
Table 4: Global Deaths, by Various Cancer Types, Through 2030
Table 5: Distribution of Global Deaths, by Various Cancer Types, 2015
Table 6: Bmi Calculation
Table 7: Bmi Categories Based On Increasing Health Risks
Table 8: Trends In Obesity Composition of the World's Population, Through 2020
Table 9: U.S. Obesity and Severe Obesity Vs. General Population, Through 2020
Table 10: Global Diabetes Types
Table 11: Global Prevalence of Diabetes, by Type, Through 2040
Table 12: Global Incidence of Congestive Heart Failure and Stroke, Through 2030
Table 13: Hypertension Epidemiology, by Patient Group, 2015
Table 14: Diagnostic Smart Pills, Key Marketed Products
Table 15: Key Fda Approvals Covering Gastrointestinal Capsule Endoscopy
Table 16: Key R&D Diagnostic Smart Pill Products
Table 17: Smart Pills For Patient Monitoring
Table 18: Smart Capsule Solutions For Drug Delivery
Table 19: Smart Pills For Oral Drug Delivery
Table 20: Global Market For Smart Pills, by Region, Through 2021
Table 21: Global Market For Smart Pills, by Application, Through 2021
Table 22: Global Market For Smart Pills, by Leading Companies, 2016
Table 23: Recent Key Strategic Deals In Smart Pills Market
Table 24: Differences In Regulatory Approval In the U.S. and Europe
Table 25: Trends In Per Capita Real Gdp Growth, by Region, 2012-2015
Table 26: List of Acronyms
List of Figures
Figure 1: Summary Figure: Global Market For Smart Pills, by Region, 2015-2021
Figure 2: Mortality From Digestive Diseases, by Region, 2015-2021
Figure 3: Epidemiology of Colon Cancer, by Region, 2000-2030
Figure 4: Global Deaths, by Various Cancer Types, 2000-2030
Figure 5: Distribution of Global Deaths, by Various Cancer Types, 2015
Figure 6: Trends In Obesity Composition of the World’S Population, 2012-2020
Figure 7: U.S. Obesity and Severe Obesity Vs. General Population, 2015-2020
Figure 8: Global Diabetes Types
Figure 9: Global Prevalence of Diabetes, by Type, 2015-2040
Figure 10: Global Incidence of Congestive Heart Failure and Stroke, 2004-2030
Figure 11: Hypertension Epidemiology, by Patient Group, 2015
Figure 12: Global Market For Smart Pills, by Region, 2015-2021
Figure 13: Global Market For Smart Pills, by Application, 2015-2021
Figure 14: Global Market For Smart Pills, by Leading Companies, 2016
Figure 15: Trends In Per Capita Real Gdp Growth, by Region, 2012-2015
- Bio-Images Research Ltd.
- Boston Scientific
- Capsovision Inc.
- Cerner Corp.
- Check-Cap Ltd.
- Chongqing Jinshan Science & Technology (Group) Co. Ltd.
- Fujifilm Holdings Corp.
- GE Healthcare
- Given Imaging Inc. (Subsidiary of Medtronic)
- Intromedic Co. Ltd.
- Karl Storz Gmbh & Co. Kg
- Medimetrics Personalized Drug Delivery Bv
- Medivators Inc. (Subsidiary of Cantel Medical)
- Olympus Corp.
- Pentax Medical Co.
- Philips Healthcare
- Proteus Digital Health
- Rani Therapeutics
- Smartpill Corp. (Subsidiary of Medtronic)
- Synectics Medical Ltd. (Trading As Synmed)